Medication review by a clinical pharmacist at the transfer point from ICU to ward: A randomized controlled trial

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 5, 2015, Pages 578-583

  Heselmans, A ^a   Van Krieken, J ^b   Cootjans, S ^c   Nagels, K ^c   Filliers, D ^c   Dillen, K ^c   De Broe, S ^c   Ramaekers, D ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Hospital Pharmacy   (Belgium)

^c Hospital Pharmacy   (Belgium)

Author keywords

clinical pharmacy; drug related problems; medication review; patient transfer; quality assurance

Indexed keywords

AGED; BELGIUM; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; INTERPERSONAL COMMUNICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT TRANSPORT; PHARMACIST; PHARMACIST ATTITUDE; PROGRAM EFFECTIVENESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; STUDY;

EID: 84941024113     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12314     Document Type: Review

References (22)

1. de Vries EN, Ramrattan MA, Smorenburg SM, et al,. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care, 2008; 17: 216-223.
2. Krahenbuhl-Melcher A, Schlienger R, Lampert M, et al,. Drug-related problems in hospitals: a review of the recent literature. Drug Saf, 2007; 30: 379-407.
3. Hume AL, Kirwin J, Bieber HL, et al,. Improving care transitions: current practice and future opportunities for pharmacists. Pharmacotherapy, 2012; 32: e326-e337.
4. Haynes KT, Oberne A, Cawthon C, et al,. Pharmacists' recommendations to improve care transitions. Ann Pharmacother, 2012; 46: 1152-1159.
5. IOM (Institute of Medicine). Health IT and patient safety: building safer systems for better care. Washington: The National Academies Press, 2012.
6. Voigt LP, Pastores SM, Raoof ND, et al,. Review of a large clinical series: intrahospital transport of critically ill patients: outcomes, timing, and patterns. J Intensive Care Med, 2009; 24: 108-115.
7. Stelfox HT, Perrier L, Straus SE, et al,. Identifying intensive care unit discharge planning tools: protocol for a scoping review. BMJ Open, 2013; 3: e002653.
8. Leape LL, Bates DW, Cullen DJ, et al,. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA, 1995; 274: 35-43.
9. Hakkarainen KM, Hedna K, Petzold M, et al,. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions-a meta-analysis. PLoS ONE, 2012; 7: e33236.
10. Kaboli PJ, Hoth AB, McClimon BJ, et al,. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med, 2006; 166: 955-964.
11. Graabaek T, Kjeldsen LJ,. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol, 2013; 112: 359-373.
12. Pronovost P, Weast B, Schwarz M, et al,. Medication reconciliation: a practical tool to reduce the risk of medication errors. J Crit Care, 2003; 18: 201-205.
13. Allenet B, Bedouch P, Rose F-X, et al,. Validation of an instrument for the documentation of clinical pharmacists interventions. Pharm World Sci, 2006; 28: 181-188.
14. Bedouch P, Sylvoz N, Charpiat B, et al,. Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP(c) website observatory. J Clin Pharm Ther, 2015; 40: 32-40.
15. Hartwig SC, Denger SD, Schneider PJ,. Severity-indexed, incident report-based medication error-reporting program. Am J Hosp Pharm, 1991; 48: 2611-2616.
16. Leape LL, Cullen DJ, Clapp MD, et al,. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA, 1999; 282: 267-270.
17. Klopotowska JE, Kuiper R, van Kan HJ, et al,. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care, 2010; 14: R174.
18. Montazeri M, Cook DJ,. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med, 1994; 22: 1044-1048.
19. Kopp BJ, Erstad BL, Allen ME, et al,. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med, 2006; 34: 415-425.
20. Gillaizeau F, Chan E, Trinquart L, et al,. Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev, 2013; 11: CD002894.
21. Lainer M, Mann E, Sonnichsen A,. Information technology interventions to improve medication safety in primary care: a systematic review. Int J Qual Health Care, 2013; 25: 590-598.
22. Nebeker JR, Hoffman JM, Weir CR, et al,. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med, 2005; 165: 1111-1116.